Everolimus decreases [U-13C]glucose utilization by pyruvate carboxylase in breast cancer cells in vitro and in vivoGerke Ariaans, Mathilde Jalving|Biomedicine & Pharmacotherapy|2024Cited by 4
Long-term outcome of high-grade serous carcinoma established in risk-reducing salpingo-oophorectomy specimens in asymptomatic BRCA1/2 germline pathogenic variant carriersIris A.S. Stroot, Marian J E Mourits, Harry Hollema et al.|Gynecologic Oncology|2024Cited by 2